Somatostatin agonists

Details Somatostatin agonists Somatostatin agonists

2005-03-08

2005-03-08

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S311000

Reexamination Certificate

active

06864234

ABSTRACT:
The present invention is directed to cyclic peptides of formula (I): X-A1-cyclo(D-Cys-A3-A4-Lys-A6-A7)-A8-Y, or a pharmaceutically acceptable salt thereof. The peptides bind selectively to the somatostatin subtype receptor type-5 and elicit an agonist effect from the somatostatin subtype receptors. The peptides are useful for treating a variety of diseases, including Cushings Syndrome, gonadotropinoma, hyperparathyroidism, Paget's disease, VIPoma, nesidioblastosis, hyperinsulinism, gastrinoma, Zollinger-Ellison Syndrome, hypersecretory diarrhea related to AIDS and other conditions, irritable bowel syndrome, pancreatitis, Crohn's Disease, systemic sclerosis, thyroid cancer, psoriasis, hypotension, panic attacks, sclerodoma, small bowel obstruction, gastroesophageal reflux, duodenogastric reflux, Graves' Disease, polycystic ovary disease, upper gastrointestinal bleeding, pancreatic pseudocysts, pancreatic ascites, leukemia, meningioma, cancer cachexia, acromegaly, restenosis, hepatoma, lung cancer, melanoma, inhibiting the accelerated growth of a solid tumor, decreasing body weight, treating insulin resistance, Syndrome X, prolonging the survival of pancreatic cells, fibrosis, hyperlipidemia, hyperamylinemia, hyperprolactinemia and prolactinemia.

REFERENCES:
patent: 4603120 (1986-07-01), Kamber
patent: 5705483 (1998-01-01), Galloway et al.
patent: 0 505 680 (1992-09-01), None
patent: P9802372 (1999-03-01), None
patent: WO 9504752 (1995-02-01), None
patent: WO 9824807 (1998-06-01), None
patent: WO 9850063 (1998-11-01), None
patent: WO 9851330 (1998-11-01), None
patent: WO 9851331 (1998-11-01), None
patent: WO 9851332 (1998-11-01), None
Stenesh. Dictionary of Biochemistry And Molecular Biology, Second Edition. New York: John Wiley & Sons. 1989, p. 347.*
Coy, D.H. et al., “Somatostatin Receptor Antagonists Based on a Mixed Neuromedin B Antagonist/Somatostatin Agonist”, Proceedings of the American Peptide Symposium, pp. 526-529, (1999) XP000917964.
Hocart, S.J. et al., “Potent Antagonists of Somatostatin: Synthesis and Biology”, Journal of Medicinal Chemistry, vol. 41, No. 7, pp. 1146-1154, (1998) XP000749590.
Raynor, K. et al., “Characterization of Cloned Somatostatin Receptors SSTR4 and SSTR5” Molecular Pharmacology, vol. 44, No. 2, pp. 385-392, (1993).

Affiliated with

Also associated with

Rating

Somatostatin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Somatostatin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatostatin agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3377380